Functional dyspepsia and its treatment methods
https://doi.org/10.14412/1995-4484-2020-87-90
Abstract
Functional dyspepsia (FD) is one of the dysregulatory lesions of the upper digestive tract. This syndrome has fairly well-defined clinical manifestations that include borderline psychopathological disorders. Its diagnosis becomes a method for ruling out organic gastrointestinal and mental illnesses. Treatment for FD is complex and includes a behavioral component, prokinetics, myotropic spasmolytics, antisecretory drugs, and tricyclic antidepressants. The efficiency of therapy directly depends on a physician's ability to choose an individualized regimen.
About the Authors
S. A. Baranov
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Competing Interests: not
Russian Federation
Sergey Baranov
8, Trubetskaya St., Build. 2, Moscow 119991
Competing Interests: not
V. M. Nechaev
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Competing Interests: not
Russian Federation
8, Trubetskaya St., Build. 2, Moscow 119991
Competing Interests: not
Yu. O. Shulpekova
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Competing Interests: not
Russian Federation
8, Trubetskaya St., Build. 2, Moscow 119991
Competing Interests: not
I. V. Supryaga
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Competing Interests: not
Russian Federation
8, Trubetskaya St., Build. 2, Moscow 119991
Competing Interests: not
A. A. Kurbatova
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Competing Interests: not
Russian Federation
8, Trubetskaya St., Build. 2, Moscow 119991
Competing Interests: not
References
1. EL-Serag HB, Talley NJ. Systematic review: The prevalence and clinical coerse of functional dyspepsia. Aliment Pharmacol Ther. 2004;19:643-54. doi: 10.1111/j.1365-2036.2004.01897.x
2. Mahadeva S, Goch K. Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol. 2006;12:2661-6. doi: 10.3748/wjg.v12.i17.2661
3. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466-79. doi: 10.1053/j.gas-tro.2005.11.059
4. Stanghellini V, Chan FK, Hasler WL, et al Gastroduodenal Disorders. Gastroenterology. 2016;150(6):1380-92. doi: 10.1053/j.gastro.2016.02.011
5. Piessevaux H, De Winter B, Louis E, et al. Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. NeurogastroenterolMotil. 2009;21:378-88. doi: 10.1111/j.1365-2982.2009.01262.x
6. Ford AC, Marwaha A, Lim A, Moayyedi P. Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia. Clin Gastroenterol Hepatol. 2010;8:401-9. doi: 10.1016/j.cgh.2009.07.020
7. McQuaid KR. Dyspepsia. In: Feldmanetal M, ed. Sleisenger and Fordtran's gastrointestinal and liver disease. 7th ed. Philadelphia-London-Toronto-Montreal-Sydney-Tokyo; 2002. P. 102-18.
8. Tally N, Ford A. Functional dyspepsia. N Engl J Med. 2015;373:1853-63. doi: 10.1056/NEJMra1501505
9. Ivashkin VT, Sheptulin AA, Lapina TL, et al. The Russian Gastroenterological Association Clinical Guidelines: diagnosis and treatment of the functional dyspepsia. Rossiiskii Zhurnal Gastroenterologii, Gepatologii, Koloproktologii. 2012;(3):80-92 (In Russ.).
10. Stanghellini V, Tack J. Gastroparesis: separate entity or just a part of dyspepsia? Gut. 2014;63:1972-8. doi: 10.1136/gutjnl-2013-306084
11. Caldarella MP, Azpiroz F, Malagelada J-R. Antrofundic dysfunction in functional dyspepsia. Gastroenterology. 2003;124:1202-29. doi: 10.1016/S0016-5085(03)00287-7
12. O'Morain C. Role of Helicobacter pylori in functional dyspepsia. World J Gastroenterol. 2006;12:2677-80. doi: 10.3748/wjg.v12.i17.2677
13. Talley NJ, Janssens L, Lauritsen K, et al. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 month follow up. Br Med J. 1999;318:833-7. doi: 10.1136/bmj.318.7187.833
14. Hanevik K, Dizdar V, Langeland N, Hausken T. Development of functional gastrointestinal disorders after Giardia lamblia infection. Gastroenterology. 2009;21(9): 27. doi: 10.1186/1471-230X-9-27
15. Holtmann G, Talley NJ. Clinician's manual on managing dyspepsia. Life Science Communications. London; 2000. 88 p.
16. Simren M, Vos R, Janssens J, Tack J. Acid infusion enhances duodenal mechanosensitivity in healthy subjects. Am J Physiol Gastrointest Liver Physiol. 2003;285:G309-G315. doi: 10.1152/ajpgi.00242.2002
17. Locke GR, Zinsmeister AR, Talley NJ, et al. Familial association in adults with functional gastrointestinal disorder. Mayo Clin. Proc. 2000;122:907-12. doi: 10.4065/75.9.907
18. Buonavolonta R, Goccorullo P, Boccia G, et al. Familial aggregation in children affected by functional gastrointestinal disorders. Gut. 2008;57 Suppl. II:A3.
19. Boekema PJ, van Dam EF, Bots ML, et al. Associations between use of alcohol, coffee and smoking and functional bowel symptoms in the general Dutch population. DDW — New Orleans; 1998. Abstract A1070.
20. Moayyedi P, Delaney BC, Vakil N. The efficacy of proton pump inhibitors in non-ulcer dyspepsia: a systematic review and economic analysis. Gastroenterology. 2004;127:1329-37. doi: 10.1053/j.gastro.2004.08.026
Review
For citations:
Baranov S.A., Nechaev V.M., Shulpekova Yu.O., Supryaga I.V., Kurbatova A.A. Functional dyspepsia and its treatment methods. Rheumatology Science and Practice. 2020;58(1):87-90. (In Russ.) https://doi.org/10.14412/1995-4484-2020-87-90
Views:
829
Email this article 